Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001612 · ClinicalTrials.gov registry record

Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)

A clinical trial, sponsored by National Eye Institute (NEI).

Completed
Registry status
170
Enrollment target

NCT00001612 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 170 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001612 has completed, sponsored by National Eye Institute (NEI).

COMPLETED
Registry status
170 participants
Enrollment target

Study Summary

Patients enrolled in the original Early Treatment Diabetic Retinopathy Study at the Clinical Center at Johns Hopkins Wilmer Eye Institute will be invited for a follow-up visit at the National Eye Institute. Visual function will be assessed with manifest refraction and standardized visual acuity measurement. The progression of retinopathy will be evaluated by ocular exam and fundus photography. A brief medical history will be obtained. The goal of this study is to evaluate the long-term results of patients whose diabetic retinopathy was treated with different strategies of scatter and/or focal laser photocoagulation.

Trial Details

FieldValue
Enrollment Target 170 participants
Start Date 1997-05
Est. Completion 2000-08

Sponsor

National Eye Institute (NEI)

221 total trials

What the Registry Record Tells You About NCT00001612

The ClinicalTrials.gov registry entry for NCT00001612 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001612 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001612 about?

NCT00001612 is a clinical study titled "Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)". Patients enrolled in the original Early Treatment Diabetic Retinopathy Study at the Clinical Center at Johns Hopkins Wilmer Eye Institute will be invited for a follow-up visit at the National Eye Institute. Visual function will be assessed with manifest refraction and standardized visual acuity meas...

What is the current status of trial NCT00001612?

This trial is currently completed. The enrollment target is 170 participants. The study started on 1997-05. Estimated completion is 2000-08.

Who is sponsoring clinical trial NCT00001612?

This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.